Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 11, 2008
Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cellsSatoshi Yamagiwa, Yasunobu Matsuda, Takafumi Ichida, et al.
Diseases (Basel, Switzerland)|June 21, 2018
Renal Impairment in Chronic Hepatitis B: A ReviewHiroteru Kamimura, Toru Setsu, Naruhiro Kimura, et al.
Clinical Immunology (Orlando, Fla.)|November 5, 2003
Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirusShiro Watanabe, Kenji Suzuki, Yusuke Kawauchi, et al.
Cancer Letters|January 24, 2012
Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signalingShun Fujimaki, Yasunobu Matsuda, Toshifumi Wakai, et al.
World Journal of Hepatology|March 7, 2017
Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis CSatoshi Yamagiwa, Toru Ishikawa, Nobuo Waguri, et al.
Biomedical Research (Tokyo, Japan)|June 20, 2014
Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantationSatoshi Yamagiwa, Yoshinobu Sato, Takafumi Ichida, et al.
Digestive Diseases and Sciences|June 8, 2012
Increased susceptibility to severe chronic liver damage in CXCR4 conditional knock-out miceAtsunori Tsuchiya, Michitaka Imai, Hiroteru Kamimura, et al.
Cancer Management and Research|August 14, 2018
Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapyTakamasa Kobayashi, Hirokazu Kawai, Oki Nakano, et al.
BMC Cancer|July 26, 2018
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapiesTakamasa Kobayashi, Hirokazu Kawai, Oki Nakano, et al.
BMC Cancer|May 12, 2017
Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trialKenya Kamimura, Takeshi Suda, Takeshi Yokoo, et al.
Pageof 10